U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
COPRELOTAMAB
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL GB221 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB221 .KAPPA.-CHAIN, DIMER
Common Name English
coprelotamab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185CERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
Code System Code Type Description
NCI_THESAURUS
C177097
Created by admin on Sat Dec 16 16:14:00 GMT 2023 , Edited by admin on Sat Dec 16 16:14:00 GMT 2023
PRIMARY
INN
11435
Created by admin on Sat Dec 16 16:14:00 GMT 2023 , Edited by admin on Sat Dec 16 16:14:00 GMT 2023
PRIMARY
FDA UNII
XQ7509L801
Created by admin on Sat Dec 16 16:14:00 GMT 2023 , Edited by admin on Sat Dec 16 16:14:00 GMT 2023
PRIMARY
CAS
2348469-84-9
Created by admin on Sat Dec 16 16:14:00 GMT 2023 , Edited by admin on Sat Dec 16 16:14:00 GMT 2023
PRIMARY
ACTIVE MOIETY
COPRELOTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966